HIV-1 inhibits IFITM3 expression to promote the infection of megakaryocytes
Journal of Molecular Cell Biology · 2025
DOI: 10.1093/jmcb/mjae042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2025. Verfasst von Cyrine Bentaleb und 7 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017-CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, F…. Hauptthemen laut MEDLINE: Megakaryocytes, HIV-1, RNA-Binding Proteins, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Protocole de Cooperation Région Hauts de France/CNRS, Sidaction, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
Despite an undetectable plasma viral load as a result of antiretroviral therapy, HIV-1-infected individuals with poor immune reconstitution harbor infectious HIV-1 within their platelets. Megakaryocytes, as platelet precursors, are the likely cellular origin of these HIV-1-containing platelets. To investigate the mechanisms that allow megakaryocytes to support HIV-1 infection, we established in vitro models of viral infection using hematopoietic stem cell-derived megakaryocytes and the megakaryocytic MEG-01 cell line. We observed HIV-1 DNA provirus integration into the megakaryocyte cell genome, self-limiting virus production, and HIV-1 protein and RNA compartmentalization, which are hallmarks of HIV-1 infection in myeloid cells. In addition, following HIV-1 infection of megakaryocyte precursors, the expression of interferon-induced transmembrane protein 3 (IFITM3), an antiviral factor constitutively expressed in megakaryocytes, was inhibited in terminally differentiated HIV-1-infected megakaryocytes. IFITM3 knockdown in MEG-01 cells prior to infection led to enhanced HIV-1 infection, indicating that IFITM3 acts as an HIV-1 restriction factor in megakaryocytes. Together, these findings indicate that megakaryocyte precursors are susceptible to HIV-1 infection, leading to terminally differentiated megakaryocytes harboring virus in a process regulated by IFITM3. Megakaryocytes may thus constitute a neglected HIV-1 reservoir that warrants further study in order to develop improved antiretroviral therapies and to facilitate HIV-1 eradication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017-CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.
- Université Paris Cité, CNRS, Inserm, Institut Cochin, F-75014 Paris, France.
- AP-HP, Ambroise Paré Hospital, F-92100 Boulogne-Billancourt, France.
- Université Paris Saclay, Versailles Saint Quentin-en-Yvelines (UVSQ), F-78047 Guyancourt, France.
ORCID-Profile: Fernando Real
Förderung
- Protocole de Cooperation Région Hauts de France/CNRS
- Sidaction
- Fondation pour la Recherche Médicale
Zitieren
APA
Bentaleb, C., Adrouche, S., Finkelstein, J., Devisme, C., Callens, N., Capron, C., Bomsel, M., & Real, F. (2025). HIV-1 inhibits IFITM3 expression to promote the infection of megakaryocytes. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjae042
Vancouver
Bentaleb C, Adrouche S, Finkelstein J, Devisme C, Callens N, Capron C, et al. HIV-1 inhibits IFITM3 expression to promote the infection of megakaryocytes. Journal of Molecular Cell Biology. 2025. doi:10.1093/jmcb/mjae042
BibTeX
@article{Bentaleb2025,
author = {Bentaleb, Cyrine and Adrouche, Souad and Finkelstein, Jade and Devisme, Christelle and Callens, Nathalie and Capron, Claude and Bomsel, Morgane and Real, Fernando},
title = {HIV-1 inhibits IFITM3 expression to promote the infection of megakaryocytes},
journal = {Journal of Molecular Cell Biology},
year = {2025},
doi = {10.1093/jmcb/mjae042}
}
EUVIMED